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Purpose: A pterygium shows tumor-like characteristics, such as proliferation, invasion, and epithelial–mesenchymal
transition (EMT). Previous reports suggest that tissue factor (TF) expression is closely related to the EMT of tumor cells,
and subsequent tumor development. In this study, we analyzed the expression and immunolocalization of TF in pterygial
and normal conjunctival tissues of humans.
Methods: Eight pterygia and three normal bulbar conjunctivas, surgically removed, were used in this study. Formalin-
fixed, paraffin-embedded tissues were submitted for immunohistochemical analysis with anti-TF antibody. Double
staining immunohistochemistry was performed to assess TF and alpha-smooth muscle actin (α-SMA) or epidermal growth
factor receptor (EGFR) expression in the pterygia.
Results: Immunoreactivity for TF was detected in all pterygial tissues examined. TF immunoreactivity was localized in
the cytoplasm of basal, suprabasal, and superficial epithelial cells. The number of TF-immunopositive cells in pterygial
epithelial cells was significantly higher than in normal conjunctival epithelial cells (p<0.001). TF immunoreactivity was
detected in α-SMA-positive or -negative pterygial epithelial cells. EGFR immunoreactivity was detected in pterygial
epithelium, which was colocalized with TF.
Conclusions: These results suggest that TF plays a potential role in the pathogenesis and development of a pterygium,
and that TF expression might be involved through EMT-dependent and -independent pathways.
A pterygium represents an epithelial and fibrovascular
configuration on the ocular surface adjoining the conjunctiva.
The pterygium invades the cornea forming a wing-like shape,
causing  visual  loss.  Pathologically,  a  pterygium  is  a
proliferative,  invasive,  and  highly  vascularized  tissue  [1].
Furthermore, there are transformed cells in pterygial tissue,
which is one of the characteristics of a tumor phenotype [2].
Kase et al. [3,4] demonstrated that proliferation activity is high
in the pterygial epithelium compared to that in the normal
conjunctiva.
The  phenomenon  of  epithelial  cells  changing  their
phenotype to fibroblastic cells after morphogenic pressure
from  injured  tissue  is  called  epithelial–mesenchymal
transition  (EMT)  [5,6].  To  develop  highly  invasive
characteristics,  epithelial  tumor  cells  change  their
morphology and function, whereby they transiently acquire
markers of mesenchymal differentiation (e.g., alpha-smooth
muscle  actin  (α-SMA)),  and  lose  some  of  their  epithelial
features  (e.g.,  E-cadherin)  [7].  Moreover,  blockade  of  E-
cadherin in cultured cancer cells similarly leads to changes in
cell shape reminiscent of EMT, and this transition gave rise
to  cells  with  a  highly  metastatic  phenotype.  It  has  been
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demonstrated that E-cadherin immunoreactivity is involved
in α-SMA-positive pterygial epithelial cells [4,8], suggesting
that EMT plays a key role in the pathogenesis of pterygium.
Tissue  factor  (TF)  is  a  transmembrane  protein  that
interacts with coagulation factor VIIa, whereby it initiates
blood coagulation. This interaction also triggers intracellular
signals, which are primarily mediated by G protein–coupled
protease-activated  receptors  in  concert  with  adhesion
molecules and several other factors [9]. TF is regulated by
oncogenic and differentiation pathways and it functions in
tumor initiation, tumor growth, angiogenesis, and metastasis
[9-11]. Indeed, it has been demonstrated that epithelial tumor
cells,  expressing  high  levels  of  TF  regulated  by  the
differentiation  pathway,  have  mesenchymal  characteristics
[9]. These results suggest that TF expression is closely related
to  the  EMT  of  tumor  cells,  and  subsequent  tumor
development.
The aim of this study was to analyze the expression and
immunolocalization  of  TF  in  pterygial  and  conjunctival
tissues in humans.
METHODS
Preparation of human tissues: Eight patients with primary
nasal pterygia who underwent surgical excision were enrolled
in  this  study.  Normal  bulbar  conjunctival  tissues  were
obtained  from  three  patients  during  cataract  surgery.  The
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63tissues  were  then  fixed  in  4%  paraformaldehyde.  After
fixation, slides were washed in phosphate-buffered saline and
processed  for  paraffin  sectioning.  Informed  consent  was
obtained according to the Declaration of Helsinki. All human
experiments  conformed  to  the  requirements  of  ethics
committee  in  Hokkaido  University  Graduate  School  of
Medicine.
Immunohistochemistry:  Dewaxed  paraffin  sections  were
immunostained  using  the  alkaline  phosphatase  complex
method.  Formalin-fixed,  paraffin-embedded  serial  tissue
sections  were  cut  at  a  4  μm  thickness  and  endogenous
peroxidase activity was inhibited by immersing the slides in
3%  hydrogen  peroxide  in  methanol  for  10  min.  As  a
pretreatment,  microwave-based  antigen  retrieval  was
performed in phosphate-buffered saline (PBS). Then, non-
Figure 1. Immunohistochemistry for tissue factor (TF) in a human pterygium and normal conjunctiva. Left panels are H&E staining and right
panels are TF immunoreactivity in two representative cases of a pterygium. TF is expressed in the cytoplasm of basal (B; red arrow head),
suprabasal (B; blue arrow head), and superficial cells (A; black arrow head). In the normal conjunctiva, however, immunoreactivity for TF is
not detected (C). The scale bar represents 50 μm.
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64specific  binding  of  the  primary  antibody  was  blocked  by
incubating the slides in blocking bovine serum for 30 min. The
slides  were  serially  incubated  with  anti-TF  monoclonal
antibody (1:50; American Diagnostic Inc., Stamford, CT) for
2 h at room temperature, followed by a biotin-conjugated goat
anti-mouse  IgG.  Positive  signals  were  visualized  using
diaminobendizine  as  a  substrate.  In  double  staining
immunohistochemistry, the sections were incubated with the
above-mentioned first antibody, followed by the rhodamine-
conjugated  secondary  antibody  for  30  min,  and  FITC-
conjugated anti-α-SMA monoclonal antibody (1:50; Abcam,
Tokyo, Japan) for 30 min at room temperature. After washing,
sections  were  mounted  with  mounting  media  with  4’,6-
diamino-2-phenylindole  (DAPI;  SlowFade®  Gold  antifade
reagent  with  DAPI;  Invitrogen,  Eugene,  OR).  Preretinal
fibrovascular membranes of proliferative diabetic retinopathy
served  as  positive  controls  for  TF  immunohistochemistry
[12]. In microscopic observation, we counted the number of
epithelial cells and TF-positive cells of pterygium or normal
conjunctiva in three fields under high power field (objective
lens 40×). Cells positively stained for anti-TF antibody were
noted by their labeling index as a percentage (%) in each
specimen, and the measurements were averaged. The results
regarding TF in pterygial tissues are presented as the mean.
To investigate the hypothesized co-localization of TF and
EGFR  in  pterygium  tissues,  double  staining
immunohistochemistry  was  performed  using  mouse
monoclonal antibody against human TF (1:50; Abcam) and
anti-rabbit  epidermal  growth  factor  receptor  (EGFR)
polyclonal  antibody  (1:100  dilution;  Santa  Cruz  Biotech,
Santa Cruz, CA) as the primary antibody. Binding of the
primary antibody was localized with the Alexa Fluor® 488
goat  anti-mouse  antibody  (1:100  dilution;  Invitrogen,
Carlsbad,  CA)  and  Alexa  Fluor®  546  goat  anti-rabbit
secondary  antibody  (1:200  dilution;  Invitrogen)     for  30
     min,  respectively.   Finally,   sections      were   mounted   with
mounting media with DAPI.
Western blot analysis: A pterygium and a normal conjunctiva
were surgically removed, and then were sonicated in lysis
buffer (1× RIPA buffer; Cell Signaling Technology, Danvers,
MA) with protease inhibitor (Roche, Basel, Switzerland) on
ice, and centrifuged at 1,3850× g for 20 min at 4 °C. These
are  stored  in  −80  °C  until  assayed.  These  samples  were
electrophoretically  separated  on  SDS–PAGE  using  a  4%
stacking  and  10%  separating  gels.  Proteins  in  gels  were
electro-transferred  (80  V,  90  min,  4  °C)  to  Hybond-P
polyvinylidene  difluoride  transfer  membranes  (GE
Healthcare,  Buckinghamshire,  UK).  After  transfer,  the
membranes were incubated for 1 h in a blocking solution
which consisted of 1% skim milk powder in PBS containing
1% tween (PBST), washed briefly in PBST, then probed with
anti-TF  monoclonal  antibody  (1:500;  above  described)  or
anti-α-SMA polyclonal antibody (1:500; Abcam, Cambridge,
UK) diluted in 5% BSA/TBST. Membranes were extensively
washed in PBST for 30 min and incubated with a 1:1000
dilution of the appropriate horseradish peroxidase-conjugated
donkey anti-mouse or anti-rabbit IgG at room temperature for
60 min. Then placed in chemiluminescent reagent (ECL plus,
GE  healthcare,  Buckinghamshire,  UK)  and  exposed  to
luminescent image analyzer (Fujifilm, Tokyo, Japan).
Statistical analysis: Student’s t-test was used for statistical
comparison of the number of TF-immunopositive epithelial
cells  between  pterygium  and  normal  control  groups.
Differences between the means were considered significant
when the probability values were <0.05.
RESULTS
Morphologically, pterygial epithelium consisted of multilayer
nuclei showing squamous metaplasia (Figure 1A). Table 1
summarizes  the  immunohistochemical  results  of  TF  in
pterygial epithelium. Immunoreactivity for TF was detected
TABLE 1. THE NUMBER OF TISSUE FACTOR (TF)-IMMUNOPOSITIVE CELLS IN PTERYGIAL EPITHELIAL AND NORMAL CONJUNCTIVAL CELLS.
Pterygia Normal conjunctivas
Age Gender TF Age Gender TF
72 M 12.7% 54 M 0%
83 M 54.8% 80 M 0%
75 F 47.7% 82 M 0%
72 M 69.8%      
71 M 69.1%      
68 M 84.3%      
77 M 45.0%      
69 M 54.9%      
  Mean 54.8%   Mean 0%
             In the Table, M indicates male and F indicates female.
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65in all pterygial tissues examined. TF immunoreactivity was
localized in the cytoplasm of basal, suprabasal, and superficial
epithelial  cells,  and  in  subepithelial  stroma  along  with
epithelium  (Figure  1A,B).  In  the  normal  conjunctival
epithelium,  however,  immunoreactivity  for  TF  was  not
detected (Figure 1C). Microvascular endothelial cells showed
a weak immunoreaction for TF in both normal conjunctiva
and pterygium. The number of TF-immunopositive cells was
significantly higher in pterygial epithelial cells than in normal
cells (p<0.001; Table 1).
Double  staining  immunohistochemistry  involving
pterygial  tissues  was  performed  for  TF  and  α-SMA
expression. α-SMA was expressed in several epithelial cells
(Figure 2B,F), where TF immunoreactivity was colocalized
(Figure 2C,G). TF immunoreactivity was also detected in α-
SMA-negative epithelial cells (Figure 2E-H).
To check the expression of TF and  α-SMA by other
methods  in  human  pterygium  and  normal  conjunctiva,
western blot analysis was performed using anti-TF and α-
SMA  antibodies.  TF  and  α-SMA  protein  expression  was
Figure  2.  Double  staining  immunohistochemistry  was  performed  for  TF  (red)  and  α-SMA  (green)  in  pterygial  tissue.  A-D:  α-SMA
immunoreactivity is colocalized with TF-positive areas in pterygial epithelial cells (D, arrows). E-H: TF immunoreactivity is detected in the
other part of epithelial cells negative for α-SMA. The scale bar represents 50 μm.
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66clearly  detected  in  both  total  proteins  extracted  from
pterygium and normal conjunctival tissues (Figure 3).
Double  staining  immunohistochemistry  for  TF  and
EGFR  was  also  performed  in  pterygial  tissue.  EGFR
immunoreactivity was observed in pterygial epithelial cells,
which was colocalized with TF in preferentially basal cells
(Figure 4).
DISCUSSION
Pterygium  has  common  biologic  features  with  epithelial
tumor, as is proliferative tissue and presence of EMT cells
[8].  It  has  been  demonstrated  that  TF  functions  in  tumor
initiation, tumor growth, angiogenesis, and metastasis [9-11].
Therefore, we supposed that TF might play a key role in the
pathogenesis of pterygium; however, TF expression has yet
to  be  determined  in  human  pterygium.  In  this  study,  we
demonstrated  that  TF  protein  was  expressed  in  pterygial
tissues  using  immunohistochemistry  and  western  blot.
Moreover,  TF  was  mainly  immunolocalized  in  pterygial
epithelial cells. As shown in Table 1, the number of TF-
positive cells was more than half of that of pterygial epithelial
cells. In contrast, TF was not expressed in normal conjunctival
epithelium. Microvascular endothelial cells showed a weak
immunoreaction for TF in both the normal conjunctiva and
pterygium, which was not significant. The result showing a
significantly higher expression of TF in pterygial epithelium
than the normal conjunctiva suggests that TF plays a role in
the pathogenesis and development of a pterygium.
EMT is a major factor in pterygium progression [8]. In
this study, protein expression of α-SMA, a classic sign of
EMT, was observed in several pterygial epithelial cells, where
TF  immunoreactivity  was  colocalized  on  double  staining
immunohistochemistry. These results indicate that epithelial
cells changing to the mesenchymal phenotype expressed TF.
In tumor cells, Milsom et al. [9] demonstrated that E-cadherin
modulated TF expression, and this could be alleviated by
EMT-like changes. These results suggest that TF expression
might be controlled by EMT in pterygium as well.
On the other hand, we found that pterygial epithelial cells,
showing a negative results for α-SMA, also expressed TF.
This suggests that the expression of TF is regulated not only
by  E-cadherin  and  EMT,  but  also  by  other  TF-related
molecules such as epidermal growth factor-receptor (EGFR).
We and other colleagues previously demonstrated that E-
Figure 3. Western blot analysis using
anti-TF and α-SMA antibodies. TF (A)
and α-SMA (B) protein expression is
clearly detected in both pterygium and
normal conjunctival tissue.
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67Figure 4. Double staining immunohistochemistry was performed for TF (green) and EGFR (red) in pterygial tissue. Nuclear staining and TF
immunoreactivity are shown in A and B, respectively. C, D: EGFR immunoreactivity was observed broadly in pterygial epithelial cells. The
scale bar represents 50 μm.
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68cadherin  and  EGFR  immunoreactivity  were  shown  by
pterygial  epithelial  cells  [4,8,13],  and  we
immunohistochemically showed colocalization with TF and
EGFR. In human squamous cell carcinoma, the activation of
EGFR stimulates TF expression, which is modulated by E-
cadherin in vitro, and an E-cadherin-neutralizing antibody led
to the upregulation of TF expression [9]. Indeed, this induction
of TF was completely inhibited by an EGFR inhibitor [9].
These findings suggest that EGFR signaling pathway may
also play an important role in the regulation of TF expression.
It has been demonstrated that subsequent EMT and the
activation of TF signaling can induce angiogenesis, tumor
growth, and invasion [9]. In fact, invasion to the cornea and
angiogenesis  are  characteristics  in  the  pathobiology  of  a
pterygium. Further investigations of the TF signaling pathway
in  the  pterygium  are  necessary  to  clarify  TF-mediated
pterygial progression. Since targeting TF has been considered
to be of therapeutic significance in tumor initiation [9], TF
may be a therapeutic molecular target to treat pterygia.
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